@coldjoint,
If its true, it needs to be rqlly looked at carefully. I dont undertand where the differences in outcomes come from. I there some differences among the overall health risks or comorbidities in the populations studied to date??
I believe theres something genomic, not something related to the efficacy of HQC. If thats the case we should be able to use tis information and bottle it.